These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3658667)

  • 21. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 2. Estimation of genetically significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):208-15. PubMed ID: 1066647
    [No Abstract]   [Full Text] [Related]  

  • 22. [How can we make mass-screening of stomach cancer more efficient using epidemiological results?].
    Kikuchi S; Wada O; Tenjin H; Inaba Y
    Gan No Rinsho; 1989 Jan; 35(2):202-6. PubMed ID: 2704128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on photofluorography for gastric mass screening].
    GOTO K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1963 Mar; 22():1258-91. PubMed ID: 13949440
    [No Abstract]   [Full Text] [Related]  

  • 24. [Early detection of gastric carcinoma in the mass survey of the stomach in a selected area in Japan (author's transl)].
    Masuda H; Inoue S; Yamakawa H
    Z Gastroenterol; 1980 May; 18(5):252-5. PubMed ID: 7434852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 1. The number of radiographs, radiographic and fluoroscopic examinations (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976; 36(1):47-55. PubMed ID: 1063369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Estimation of population doses from chest mass screening, 1975 (author's transl)].
    Hashizuma T; Maruyama T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1977 Jun; 37(6):590-9. PubMed ID: 917744
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Int J Cancer; 2006 May; 118(9):2315-21. PubMed ID: 16331632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estimation of frequency, population doses and stochastic risks in brachytherapy in Japan, 1983].
    Maruyama T; Nishizawa K; Kumamoto Y; Noda Y; Iwai K; Furuya Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 May; 48(5):633-40. PubMed ID: 3412876
    [No Abstract]   [Full Text] [Related]  

  • 29. [Benefit-risk analysis for mass screening of stomach cancer in Japan. II. Genentic risk and cost of mass screening (author's transl)].
    Iinuma TA; Tateno Y; Umegaki Y; Hashizume T; Kitabatake T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Jul; 38(7):625-32. PubMed ID: 704295
    [No Abstract]   [Full Text] [Related]  

  • 30. [Stochastic risk estimation from medical x-ray diagnostic examinations. 2. Risk estimates of individuals from x-ray diagnosis (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Iwai K; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):59-70. PubMed ID: 7232112
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of various methods of photofluorography of the stomach].
    Ide N; Watanabe H; Okubo T
    Rinsho Hoshasen; 1967 Feb; 12(2):123-30. PubMed ID: 5183199
    [No Abstract]   [Full Text] [Related]  

  • 32. [Estimation of stochastic risk from computed tomographic examinations in Japan. 2. Organ or tissue doses by computed tomographic examinations (author's transl)].
    Nishizawa K; Maruyama T; Iwata T; Furuya Y; Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Mar; 41(3):242-9. PubMed ID: 7279619
    [No Abstract]   [Full Text] [Related]  

  • 33. [Standardised radiological investigation of the stomach with double contrast and fluorography (author's transl)].
    Seyss R
    Wien Klin Wochenschr; 1979 May; 91(11):391-5. PubMed ID: 463040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 3. Per caput mean marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):216-24. PubMed ID: 1066648
    [No Abstract]   [Full Text] [Related]  

  • 35. Doses from Hiroshima mass radiologic gastric surveys.
    Antoku S; Sawada S; Russell WJ
    Health Phys; 1980 May; 38(5):735-42. PubMed ID: 7390838
    [No Abstract]   [Full Text] [Related]  

  • 36. [Benefit-risk analysis for mass screening of stomach cancer in Japan. I. Life-saving vs. loss of life (author's transl)].
    Iinuma TA; Tateno Y; Hashizume T; Umegaki Y; Kitabatake T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1977 Dec; 37(12):1109-21. PubMed ID: 609531
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mass survey for gastric cancer].
    Fuchigami A
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2258-64. PubMed ID: 4073923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper gastrointestinal mass survey with panendoscopy in a workplace.
    Miki K; Hirayama Y; Ichinose M; Niwa H; Oka H; Oda T
    Gastrointest Endosc; 1982 May; 28(2):70-2. PubMed ID: 7084645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric photofluorography; an analysis of 10,187 survey examinations done in North Carolina.
    VAUGHAN WW; REEVES RJ
    N C Med J; 1956 Jan; 17(1):19-26. PubMed ID: 13280157
    [No Abstract]   [Full Text] [Related]  

  • 40. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study.
    Miyamoto A; Kuriyama S; Nishino Y; Tsubono Y; Nakaya N; Ohmori K; Kurashima K; Shibuya D; Tsuji I
    Prev Med; 2007 Jan; 44(1):12-9. PubMed ID: 16956654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.